Close Menu

NEW YORK – Bruker has received the CE mark for a six-plex PCR-based test for SARS-CoV-2 that can distinguish the virus that causes COVID-19 from four other endemic coronaviruses that can cause the common cold.  

Specifically, the FluoroType SARS-CoV-2 plus assay detects two genes of the SARS-CoV-2 genome as well as four other human coronaviruses from nasopharyngeal and oropharyngeal swabs in viral transport medium.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Sponsored by
Thermo Fisher Scientific

As the world continues to contend with coronavirus and a surge in the infection rate, labs are required to run more samples than ever before. 

Sponsored by

Developing a fully integrated consumable cartridge for an automated diagnostic platform is a significant challenge. More challenging still is developing such a cartridge in response to a deadly global virus pandemic amid market uncertainty and extraordinary time constraints.